translate
en
arrow_drop_down
translate
en
arrow_drop_down
gl
es
Sign in
Research
PORTAL
Groups
Researchers
Results
Guillermo
Debén Ariznavarreta
Mutua de Terrassa
Terrassa, España
You are in
Collaborations
Mutua de Terrassa
Publications in collaboration with researchers from Mutua de Terrassa (1)
2022
A randomized phase II study comparing consolidation with a single dose of 90Y ibritumomab tiuxetan vs. maintenance with rituximab for two years in patients with newly diagnosed follicular lymphoma responding to R-CHOP. Long-term follow-up results
Leukemia and Lymphoma, Vol. 63, Núm. 1, pp. 93-100